BRIEF-Shanghai Fosun Pharmaceutical Receives Regulatory Approval For Bond Issuance

Reuters02-26 17:33

BRIEF-<a href="https://laohu8.com/S/600196">Shanghai Fosun</a> Pharmaceutical Receives Regulatory Approval For Bond Issuance

Feb 26 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 600196.SS:

SAYS IT RECEIVED SECURITIES REGULATOR'S APPROVAL TO ISSUE UP TO 6 BILLION YUAN ($877.13 million) OF BONDS

Source text

Further company coverage: 600196.SS

($1 = 6.8405 Chinese yuan renminbi)

(Reporting by Beijing Newsroom)

((yukun.zhang@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2614199380?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-26 17:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614199380","market":"nz","top_or_hot":-1,"title":"BRIEF-Shanghai Fosun Pharmaceutical Receives Regulatory Approval For Bond Issuance","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/600196\">Shanghai Fosun</a> Pharmaceutical Receives Regulatory Approval For Bond Issuance</title></head><body><p><span>Feb 26 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/SFOSF\">Shanghai Fosun Pharmaceutical Group Co Ltd</a> <span>600196.SS</span>:</p><ul><li><p>SAYS IT RECEIVED SECURITIES REGULATOR'S APPROVAL TO ISSUE UP TO 6 BILLION YUAN ($877.13 million) OF BONDS</p></li></ul><p>Source text</p><p>Further company coverage: <span>600196.SS</span></p><p>($1 = 6.8405 Chinese yuan renminbi)</p><p> (Reporting by Beijing Newsroom)</p><p> ((yukun.zhang@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Shanghai Fosun Pharmaceutical Receives Regulatory Approval For Bond Issuance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Shanghai Fosun Pharmaceutical Receives Regulatory Approval For Bond Issuance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-26 17:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/600196\">Shanghai Fosun</a> Pharmaceutical Receives Regulatory Approval For Bond Issuance</title></head><body><p><span>Feb 26 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/SFOSF\">Shanghai Fosun Pharmaceutical Group Co Ltd</a> <span>600196.SS</span>:</p><ul><li><p>SAYS IT RECEIVED SECURITIES REGULATOR'S APPROVAL TO ISSUE UP TO 6 BILLION YUAN ($877.13 million) OF BONDS</p></li></ul><p>Source text</p><p>Further company coverage: <span>600196.SS</span></p><p>($1 = 6.8405 Chinese yuan renminbi)</p><p> (Reporting by Beijing Newsroom)</p><p> ((yukun.zhang@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0012","symbol_name":"证金概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nL4N3ZM0U4:1","article_id":"2614199380","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2614199380","pubTimestamp":1772098420,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Shanghai Fosun Pharmaceutical Receives Regulatory Approval For Bond IssuanceFeb 26  - Shanghai Fosun Pharmaceutical Group Co Ltd 600196.SS:SAYS IT RECEIVED SECURITIES REGULATOR'S APPROVAL TO ISSUE UP TO 6 BILLION YUAN  OF BONDSSource textFurther company coverage: 600196.SS  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600196":"复星医药","BK0012":"证金概念","BK0196":"行业龙头","BK0175":"白马股","BK0060":"抗癌","BK0187":"一线龙头","BK0028":"国家队","BK0239":"医药制造","BK0183":"MSCI概念","BK0096":"民营医院","BK0188":"融资融券"},"translate_title":"简报-上海复星医药获监管部门批准发债","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600196":0.9},"content_text":"BRIEF-Shanghai Fosun Pharmaceutical Receives Regulatory Approval For Bond IssuanceFeb 26 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd 600196.SS:SAYS IT RECEIVED SECURITIES REGULATOR'S APPROVAL TO ISSUE UP TO 6 BILLION YUAN ($877.13 million) OF BONDSSource textFurther company coverage: 600196.SS($1 = 6.8405 Chinese yuan renminbi) (Reporting by Beijing Newsroom) ((yukun.zhang@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2614199380","isCrawlerRequest":true}